Advertisement

Topics

Jazz Pharmaceuticals Announces FDA Approval of Vyxeos™ (daunorubicin and cytarabine) Liposome ...

10:10 EDT 3 Aug 2017 | BioMedReports - Blog

"Vyxeos is the first new chemotherapy advance in more than 40 years for adults with newly-diagnosed therapy-related AML or AML with myelodysplasia-related changes," said Bruce

Read more...

Original Article: Jazz Pharmaceuticals Announces FDA Approval of Vyxeos™ (daunorubicin and cytarabine) Liposome ...

NEXT ARTICLE

More From BioPortfolio on "Jazz Pharmaceuticals Announces FDA Approval of Vyxeos™ (daunorubicin and cytarabine) Liposome ..."

Quick Search
Advertisement